---
title: "X4 Pharmaceuticals issues inducement stock options for 12,000 shares at $3.98 each"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294736223.md"
description: "X4 Pharmaceuticals issued inducement stock options for 12,000 shares to new employees under its 2019 Inducement Equity Incentive Plan. The options have a 10-year term with an exercise price of $3.98 per share, based on the July 31 closing price. Vesting occurs over four years: 25% after 12 months, followed by monthly vesting over the remaining 36 months, contingent on continued employment."
datetime: "2026-08-03T20:39:50.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294736223.md)
  - [en](https://longbridge.com/en/news/294736223.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294736223.md)
---

# X4 Pharmaceuticals issues inducement stock options for 12,000 shares at $3.98 each

-   X4 Pharmaceuticals issued inducement stock options covering 12,000 shares to new employees under its 2019 Inducement Equity Incentive Plan. \* Options carry a 10-year term with an exercise price of USD 3.98 per share, set at the July 31 close. \* Vesting runs four years: 25% after 12 months, then monthly over the next 36 months, subject to continued employment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. X4 Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608031630PRIMZONEFULLFEED9802703) on August 03, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [XFOR.US](https://longbridge.com/en/quote/XFOR.US.md)

## Related News & Research

- [Alpaca Launches Mentionify Generative Engine Optimization Platform and Stock Option Plan](https://longbridge.com/en/news/295456541.md)
- [Elkem terminates share option program, cancels 5,017,333 outstanding options](https://longbridge.com/en/news/295490899.md)
- [J&J CEO Joaquin Duato sells USD 32.07 million in common shares](https://longbridge.com/en/news/295974523.md)
- [IceCure expands 2024 employee equity plan share reserve to 2,612,667 shares](https://longbridge.com/en/news/295971435.md)
- [Arcutis Biotherapeutics grants 143,500 RSUs, 37,000 stock options to new hires under inducement plan](https://longbridge.com/en/news/295272046.md)